Business Context and Reporting Period
This Form 8-K is a current report filed by AVROBIO, Inc. (not Tectonic Therapeutic, Inc.) on June 20, 2018. The filing discloses corporate governance changes and charter amendments effective immediately following the consummation of the Company's initial public offering (IPO) on June 25, 2018.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and legal structural changes.
Material Changes
- Board Appointment: Phillip B. Donenberg was elected to the Board of Directors effective June 20, 2018, and appointed Chair of the Audit Committee. He serves as a Class III director until the annual meeting following December 31, 2021.
- Compensation Arrangements: Mr. Donenberg received an option to purchase 18,743 shares of common stock. His annual service retainer is $55,000, which includes a $5,000 fee for serving as Audit Committee Chair.
- Charter Amendments: The Company filed a Fourth Amended and Restated Certificate of Incorporation authorizing 150,000,000 shares of common stock and 10,000,000 shares of undesignated preferred stock, while eliminating references to previous preferred stock series.
- Bylaw Amendments: New bylaws eliminated the ability for stockholders to take action by written consent or call special meetings, established procedures for stockholder proposals and director nominations, and adopted exclusive forum selection clauses.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies are detailed in this report beyond the standard disclosure of the indemnification agreement entered into with the new director.
Investor Verification Checklist
- Verify the exact date of the IPO consummation (June 25, 2018) to confirm the effective date of the new charter and bylaws.
- Review the attached Exhibit 3.1 (Restated Certificate) and Exhibit 3.2 (Amended Bylaws) for full legal text regarding stock authorization and governance procedures.
- Confirm the terms of the 2018 Stock Option and Incentive Plan regarding the 18,743 shares granted to Mr. Donenberg.
- Note that the registrant is an emerging growth company.